A federal judge on Thursday ordered the U.S. Food and Drug administration to produce the documents it’s relied on to license the Pfizer-BioNTech COVID-19 vaccine, at a rate of 55,000 pages a month. The rate of 55,000 pages a month would mean the FDA has just over eight months to fully produce all of Pfizer’s pre-licensure safety data—far more than what the FDA proposed in December 2021, which was to produce documents at a minimum rate of 500 pages a month or faster where feasible. That rate would have effectively given the agency a minimum of 75 years to fully produce the data, Aaron Siri, a lawyer working on the case, previously observed. Specifically, U.S. District Judge Mark Pittman ordered the FDA to produce more than 12,000 pages on or before Jan. 31, which was what the FDA had proposed. Pittman then ordered the agency to “produce the remaining documents at a rate of 55,000 pages …